Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

TAPI (Technology & API Services) Names Serge Rogasik CEO to lead next chapter of growth and competitiveness

$TEVAPress releaseSep 30, 2026, 4:32 PM ETRead the release

TAPI, Teva's active pharmaceutical ingredients and CDMO business, appointed Serge Rogasik as its Chief Executive Officer. Rogasik brings 25+ years leading specialty ingredients and chemicals carve-outs, most recently transforming Kensing from a BASF single-site carve-out into a global platform under One Rock Capital Partners.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.